Activity: Participating in or organising an event › Participation in conference › Academic
Description
Long-Term Efficacy and Safety of Canakinumab in patients with active Systemic Juvenile Idiopathic Arthritis (SJIA): Results from a Phase III Extension Study - PReS Congres